NDA 50117, held by Apothecon. Methicillin Sodium.
As of Nov 15, 2026, NDA 50117 (Staphcillin), held by Apothecon, was not approved, with 0 approved supplements and 0 published complete response letters.
| StaphcillinEQ 900MG BASE/VIAL · injectable;injection | Methicillin Sodium | Discontinued |
| StaphcillinEQ 3.6GM BASE/VIAL · injectable;injection | Methicillin Sodium | Discontinued |
| StaphcillinEQ 5.4GM BASE/VIAL · injectable;injection | Methicillin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters